Navigation Links
Researchers at IRB Barcelona uncover new clues about the origin of cancer
Date:6/7/2012

A study by Travis H. Stracker, researcher at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with scientists at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, reveals new information about the origin of tumors. In this study, published in the journal Proceedings of the National Academy of Sciences (PNAS), the scientists postulate that the initiation of a tumor and the type and aggressivity of the same depend on a specific combination of defects in several processes that safeguard cell integrity, such as DNA repair pathways and cell cycle check-points. The study also demonstrates that mice with a high degree of chromosomal instability and defective programmed cell death (apoptosis), two hallmarks of cancer, rarely develop tumors.

"Whether or not a tumor develops depends on the moment of the cell cycle in which the damage occurs, which repair pathways components are affected, and which others are impaired in terms of apoptosis and cell cycle arrest", explains the North-American Travis H. Stracker, head of the "Genomic Instability and Cancer" group and an expert in DNA repair pathways and its implications on human health. In this study, H. Stracker and his team report on some of these combinations for the initiation of cancer and in different kinds of tissue. "The paper points out that our understanding of which aspects of damage response promote tumorigenesis and where they play a role in the process needs to be investigated further because it shows that it has been generalized and that there is a lot of specifics that are not at all clear."

The researchers utilized mice carrying mutations in key DNA repair genes involved in cancer. Next, they combined them with other mutations affecting cell cycle checkpoints or apoptosis until they hit upon the combinations that are sufficient to initiate tumorigenesis or to generate certain types of tumors. "It is like deconstructing cancer to find the factors responsible for it appearing", says H. Stracker.

During DNA replication in a dividing cell there is a series of checkpoints to test that duplication is taking place properly. If the cell detects errors in any of these phases, cell growth is halted and highly complex DNA repair processes are triggered. If the repair is defective and the cell accumulates many genomic errors, "watch-out" proteins step in, such as tumor suppressor p53. Such proteins activate programmed cell death (apoptosis) or cell cycle arrest (senescence). "A very complex network of pathways and proteins are involved", explains the researcher. "This study demonstrates that genomic instability per se is not sufficient to initiate a tumor and that we cannot generalize. We need to study the origin of different kinds of cancer in much greater depth and although it is as difficult as trying to find a needle in a haystack, we are slowly identifying the parts on which we should focus", he goes on to explain. The detection of the main players that cause different kinds of cancer could be of great interest for the design of new diagnostic tools and specific treatments.


'/>"/>
Contact: Snia Armengou
sonia.armengou@irbbarcelona.org
34-934-037-255
Institute for Research in Biomedicine (IRB Barcelona)
Source:Eurekalert  

Related medicine news :

1. HIV drug may slow down metastatic breast cancer, say researchers at Jeffersons Kimmel Cancer Center
2. Student researchers seek to develop new therapies for cancer
3. Researchers call for obesity prevention efforts to focus on community-wide systems
4. Listening in, researchers learn about end-of-life communication
5. 29 Johns Hopkins stem cell researchers awarded funding
6. Just do it! not good enough for cancer patients, UR researchers say
7. Researchers identify a life-and-death molecule on chronic leukemia cells
8. GW researchers discover biomarker for advanced bile duct fibrosis and bile duct cancer
9. Researchers restore neuron function to brains damaged by Huntingtons disease
10. UC San Diego researchers receive new CIRM funding
11. Ben-Gurion U. researchers successfully test solar desalination system for arid land agriculture
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers at IRB Barcelona uncover new clues about the origin of cancer
(Date:5/3/2016)... ... May 03, 2016 , ... Cosmetic surgeon Dr. Mark Youssef ... 2014, incorporating the injectable filler into his menu of services to give his patients ... than a year later, he’s still improving his approach to ensure he stays at ...
(Date:5/3/2016)... ... May 03, 2016 , ... Excessive panting in the car or cowering when ... owners often think anxiety only manifests itself as trembling or ‘tail between the legs,’ ... things that be done about it,” says Dr. Jim Lowe, technical services veterinarian for ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... that it is launching a new client service center in La Vergne, Tennessee, ... and will provide the full range of Empyrean client services. , “Our Nashville-area ...
(Date:5/3/2016)... ... May 03, 2016 , ... Each year, about 800,000 people suffer ... across the United States and account for one death every four minutes. Many ... permanently disabled. HCR ManorCare is launching a video series called “Your Brain,” in conjunction ...
(Date:5/3/2016)... ... 03, 2016 , ... United Benefit Advisors (UBA), the nation’s ... latest addition to its elite stable of Partner Firms. Benefits Alliance Insurance Services ... and Paul Vincent. The Firm is also led by industry and thought-leading COO ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... from Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and increase market presence. ... ... ... ... Sino-German High-Tech ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
(Date:5/3/2016)... , May 3, 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is ... a video of two patients who tell their personal story and encourage those at risk ... Meet Jacque: Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
Breaking Medicine Technology: